ENDRA LIFE SCIENCES INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
ENDRA LIFE SCIENCES INC. - More news...
ENDRA LIFE SCIENCES INC. - More news...
- ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
- ENDRA Life Sciences Submits Technical File for CE Mark
- ENDRA Life Sciences to present at H.C. Wainwright 3rd Annual NASH Investor Conference
- ENDRA Life Sciences Reports Completion and Top Level Findings of Second Phase of Robarts Research Institute Liver Fat Feasibility Study
- ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019
- ENDRA Life Sciences to Participate at Upcoming Investor Conferences
- ENDRA Life Sciences Reports Second Quarter 2019 Financial & Operational Results
- ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
- ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET
- ENDRA Life Sciences and Rocky Vista University College of Osteopathic Medicine Partnering for Clinical Study of Thermo Acoustic Enhanced Ultrasound Device
- ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the 2nd International Conference on Fatty Liver (ICFL 2019)
- ENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial Officer
- ENDRA Life Sciences Reports First Quarter 2019 Financial & Operational Results
- ENDRA Life Sciences to Host First Quarter 2019 Results Conference Call on Tuesday, May 14, 2019 at 4:30 p.m. ET
- ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue
- ENDRA Life Sciences Receives ISO 13485 Certification
- ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat
- ENDRA Life Sciences Reports Full Year 2018 Financial & Operational Results
- ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET
- ENDRA Life Sciences Announces Artificial Intelligence Initiative
- ENDRA Life Sciences Issues Shareholder Letter
- ENDRA Life Sciences Provides Update on First Human Study
- ENDRA Life Sciences to Present at the 11th Annual LD Micro Main Event on December 5, 2018
- ENDRA Life Sciences to Present at Upcoming Investor Conferences
- ENDRA Life Sciences Announces Closing of Public Offering and Exercise of Over-Allotment Option
- ENDRA Life Sciences Prices Public Offering of Common Stock
- ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
- ENDRA Life Sciences Reports Third Quarter 2018 Financial Results
- ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at Three Global Liver and Imaging Conferences in November 2018
- ENDRA Life Sciences to Host Third Quarter 2018 Results Conference Call on Monday, November 5, 2018 at 4:30 p.m. ET
